Patent · US Active

Cyclic peptides multimers targeting alpha-4-beta-7 integrin

US11111273B2 · kind B2 · utility

2Cited by
9References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 10, 2017
Grant dateSep 7, 2021
Priority date—
Expiry dateDec 16, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is described herein, multimers comprising a plurality of compounds covalently linked together, the compounds independently being of formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.